Assignee
NEUROVENTI
KR·2 granted patents·1 pending application·0 citations·filing 2017–2021
Top patents by PatentIndex Score
3 records- 0144US12396983B2Composition comprising rilmenidine compound as active ingredient for treatment of fragile X syndrome or related developmental disabilityNEUROVENTI·Filed 2021·Granted Aug 26, 2025·0 cites·5 claims
- 0241US10787426B2Method of treating autism spectrum disorders using piperazine-1-carboxamidine or pharmaceutically acceptable salt thereofNEUROVENTI·Filed 2017·Granted Sep 29, 2020·0 cites·6 claims
- 0336US2023024384A1Composition comprising lisuride compound for treating fragile x syndrome or related developmental disordersNEUROVENTI·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →